当前位置: 首页 > 期刊 > 《健康必读·下旬刊》 > 2018年第4期
编号:13310735
血栓通注射液治疗急性脑梗的临床疗效(1)
http://www.100md.com 2018年4月1日 《健康必读·下旬刊》 2018年第4期
     【摘 要】目的:对血栓通注射液治疗急性脑梗的临床疗效作探讨。方法:将我院2015年1月-2017年12月收治的急性脑梗患者76例纳为研究对象,两组患者均接受常规药物治疗,并将其根据入院单双顺序均分组为:对照组38例患者用低分子右旋糖酐注射液治疗,观察组38例患者用血栓通注射液治疗;将两组患者各项临床数据详细整理后作对比分析。结果:治疗后观察组患者NIHSS及Barthel评分(12.25±3.22)分、(60.27±11.51)分明显优于对照组(18.13±2.27)分、(48.65±10.38)分,P<0.05;观察组临床治疗总有效率97.4%比对照组73.7%高,P<0.05。结论:急性脑梗患者接受血栓通注射液治疗的效果更佳。

    【关键词】血栓通注射液;右旋糖酐注射液;急性脑梗

    Abstract Objective:to explore the clinical effect of Xueshuantong injection in treating acute cerebral infarction. Methods: 76 patients with acute cerebral infarction treated in our hospital from January 2015 to December 2017 were treated with routine drugs. The patients in the control group were treated with low-molecular-weight dextran injection and 38 patients in the observation group were treated with Xueshuantong injection. Results: the NIHSS and Barthel scores were 12.25 ±3.22 in the observation group after treatment.The score of 60.27 ±11.51 was significantly better than that of the control group (48.65 ±10.38) (P< 0.05) ......
1 2下一页

您现在查看是摘要页,全文长 3543 字符